APA

Olver I. N., Hercus T., Lopez A., Vadas M., Somogyi A. A., Doyle I., Foster D. J. R., Keefe D., Taylor A., Brown M., To L. B., Cole J., Rawling T., Cambareri B., Myers M., Olszewski N., Bastiras S., Senn C., Hey A., Verma M. & Wigley P. (20021017). A phase I study of the GM-CSF antagonist E21R. : Cancer chemotherapy and pharmacology.

Chicago

Olver Ian N, Hercus Tim, Lopez Angel, Vadas Matthew, Somogyi Andrew A, Doyle Ian, Foster David J R, Keefe Dorothy, Taylor Anne, Brown Michael, To L Bik, Cole Julie, Rawling Trevor, Cambareri Bronwyn, Myers Melinda, Olszewski Nancy, Bastiras Stan, Senn Carol, Hey Allan, Verma Meera and Wigley Peter. 20021017. A phase I study of the GM-CSF antagonist E21R. : Cancer chemotherapy and pharmacology.

Harvard

Olver I. N., Hercus T., Lopez A., Vadas M., Somogyi A. A., Doyle I., Foster D. J. R., Keefe D., Taylor A., Brown M., To L. B., Cole J., Rawling T., Cambareri B., Myers M., Olszewski N., Bastiras S., Senn C., Hey A., Verma M. and Wigley P. (20021017). A phase I study of the GM-CSF antagonist E21R. : Cancer chemotherapy and pharmacology.

MLA

Olver Ian N, Hercus Tim, Lopez Angel, Vadas Matthew, Somogyi Andrew A, Doyle Ian, Foster David J R, Keefe Dorothy, Taylor Anne, Brown Michael, To L Bik, Cole Julie, Rawling Trevor, Cambareri Bronwyn, Myers Melinda, Olszewski Nancy, Bastiras Stan, Senn Carol, Hey Allan, Verma Meera and Wigley Peter. A phase I study of the GM-CSF antagonist E21R. : Cancer chemotherapy and pharmacology. 20021017.